First Horizon Advisors, Inc. Ironwood Pharmaceuticals Inc Transaction History

First Horizon Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$8.25 - $11.35 $2,788 - $3,836	-338 Reduced 80.09%	84 $0
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $3,505 - $4,245	338 Added 402.38%	422 $4,000
Q3 2022 Nov 09, 2022	BUY	$10.14 - $12.38 $851 - $1,039	84 New	84 $1,000
Q4 2021 Feb 09, 2022	SELL	$10.86 - $13.95 $130 - $167	-12 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$11.92 - $13.92 $143 - $167	12 New	12 $0
Q2 2019 Aug 05, 2019	SELL	$9.8 - $12.89 $1,038 - $1,366	-106 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$8.27 - $12.73 $876 - $1,349	106 New	106 $0

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.